Clinical Trials Browser

INDUSTRY × Adenocarcinoma × Ipilimumab × Clear all

NCT00083278 2012-04-27

Study of MDX-010 in Stage IV Breast Cancer

Phase 2 Completed

Adenocarcinoma, Breast Neoplasms